<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05080088</url>
  </required_header>
  <id_info>
    <org_study_id>21.06.06</org_study_id>
    <nct_id>NCT05080088</nct_id>
  </id_info>
  <brief_title>Retrospective Evaluation of 3 Colonic Adenoma Detection Strategies</brief_title>
  <acronym>COLODETECT</acronym>
  <official_title>A Pilot Study: Retrospective Evaluation of 3 Colonic Adenoma Detection Strategies During a Colonoscopy: Endoscopy Cap Associated With the Artificial Intelligence GI GENIUS ™ System, the Artificial Intelligence GI GENIUS ™ Alone and Colonoscopy Alone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective study, single blind (patient), allowing a posteriori clinical data collection&#xD;
      of 90 patients during their passage to the ambulatory endoscopy circuit, to consider 3 groups&#xD;
      and thus to deduce a colonic adenoma detection rate for each arm :&#xD;
&#xD;
        -  Colonoscopy Only Group&#xD;
&#xD;
        -  Artificial intelligence only group (IA GI GENIUS ™ alone)&#xD;
&#xD;
        -  Endoscopic Cap and Artificial Intelligence Group (endoscopy cap associated with the GI&#xD;
           GENIUS ™ IA System)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 6, 2021</start_date>
  <completion_date type="Actual">July 8, 2021</completion_date>
  <primary_completion_date type="Actual">July 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Colonic Adenomas Detection Rate according to the use of the Combine Techniques GENIUS software - Cap or Only GENIUS software</measure>
    <time_frame>4 months</time_frame>
    <description>number of colonoscopies with the discovery of at least 1 colonic adenoma out of the total number of colonoscopies according to the use of colonoscopy alone / artificial intelligence alone / artificial intelligence combined with the endoscopic cap.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adenomas Rate according to their morphology</measure>
    <time_frame>4 months</time_frame>
    <description>according to Paris classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adenomas Rate according to their size</measure>
    <time_frame>4 months</time_frame>
    <description>&lt; 0,5mm / 0-5-10mm / &gt; 10mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adenomas Rate according to their histology</measure>
    <time_frame>4 months</time_frame>
    <description>according to Vienne classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caecal Intubation Rate</measure>
    <time_frame>4 months</time_frame>
    <description>Complete colonocopy rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Withdrawal time</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effects</measure>
    <time_frame>4 months</time_frame>
    <description>Haemorrhages, Perforation</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">90</enrollment>
  <condition>Adenoma Colon</condition>
  <condition>Colorectal Cancer</condition>
  <condition>Colorectal Polyp</condition>
  <condition>Colonic Adenocarcinoma</condition>
  <arm_group>
    <arm_group_label>Colonoscopy Only Group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Artificial intelligence GI GENIUS ™ only Group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Endoscopic Cap and Artificial Intelligence GI GENIUS ™ Group</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients are recruited during a pre-colonoscopy consultation, carried out by the&#xD;
        gastroenterologist in current practice&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria :&#xD;
&#xD;
          -  18 years &lt; Patient &lt; 85 years&#xD;
&#xD;
          -  Need to perform a primary and / or secondary screening colonoscopy for colorectal&#xD;
             cancer&#xD;
&#xD;
          -  Patients candidates for outpatient care&#xD;
&#xD;
        Exclusion Criteria :&#xD;
&#xD;
          -  History of inflammatory digestive tract disease&#xD;
&#xD;
          -  Failed previous colonoscopy&#xD;
&#xD;
          -  Known familial polyposis&#xD;
&#xD;
          -  Biopsy / polypectomy contraindication (coagulation disorder, treatment with&#xD;
             CLOPIDOGREL / Anticoagulant)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>CHU Nîmes</name>
      <address>
        <city>Nîmes</city>
        <state>Gard</state>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 2, 2021</study_first_submitted>
  <study_first_submitted_qc>October 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2021</study_first_posted>
  <last_update_submitted>October 2, 2021</last_update_submitted>
  <last_update_submitted_qc>October 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire de Nīmes</investigator_affiliation>
    <investigator_full_name>Clément Delliot</investigator_full_name>
    <investigator_title>medical student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

